Sufferers with Renal Impairment Ritalin hasn't been researched in renally-impaired sufferers. Renal impairment is expected to possess small impact on the pharmacokinetics of methylphenidate because lower than 1% of a radiolabeled dose is excreted in the urine as unchanged compound, and the key metabolite (ritalinic acid), has little or no pharmacol